Webinar: MitoToxScreen: Advancing Accurate Mitochondrial Toxicity Screening
Join us for an in-depth webinar introducing MitoToxScreen, a scalable screening assay designed to support the identification of mitochondrial liabilities.
Mitochondrial dysfunction is an important mechanism underlying adverse effects associated with pharmaceuticals, agrochemicals, and other chemical products. Identifying mitochondrial liabilities early can support better decision-making and help avoid costly late-stage failures.
Currently available in vitro assays differ in sensitivity, specificity, and mitochondrial endpoints they assess, making it challenging to select the most appropriate method and interpret the biological relevance of a positive result. Additionally, throughput is relatively low in some assays, limiting their applicability in early decision-making steps.
During this webinar, we will introduce MitoToxScreen, a new in vitro assay designed to address these limitations by combining CHOP-GFP reporter activation with the glucose/galactose metabolic switch in a scalable assay. This dual endpoint improves accuracy and reduces misleading positive findings.
Key learning points
- Why NAMs are increasingly important for mitochondrial toxicity testing.
- What makes MitoToxScreen a unique approach to mitochondrial toxicity testing.
- How MitoToxScreen was established and validated.
- How MitoToxScreen can be applied in your testing pipeline.
Why attend
This webinar is ideal for professionals involved in drug, agrochemical, chemical, and product safety assessment, particularly those interested in identifying mitochondrial liabilities earlier in the development pipeline.
Whether you are already using mitochondrial toxicity assays or are exploring options for your testing pipeline, this webinar will provide practical insights into the MitoToxScreen approach and its potential applications.
Meet the speakers and organizers
SPEAKER: Tamara Meijer, Study Director at Toxys.
HOST: Katarina Spencer, Sales Manager at Toxys
Webinar | MitoToxScreen: Advancing Accurate Mitochondrial Toxicity Screening
09 September 2026, 4:00-5:00 pm CEST
Event website: Register Now
